Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Prestige Consumer Healthcare (PBH) Receivables: 2009-2025

Historic Receivables for Prestige Consumer Healthcare (PBH) over the last 16 years, with Sep 2025 value amounting to $199.0 million.

  • Prestige Consumer Healthcare's Receivables rose 21.68% to $199.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $729.0 million, marking a year-over-year increase of 3.74%. This contributed to the annual value of $194.3 million for FY2025, which is 0.59% up from last year.
  • Prestige Consumer Healthcare's Receivables amounted to $199.0 million in Q3 2025, which was up 18.17% from $168.4 million recorded in Q2 2025.
  • In the past 5 years, Prestige Consumer Healthcare's Receivables ranged from a high of $199.0 million in Q3 2025 and a low of $114.7 million during Q1 2021.
  • In the last 3 years, Prestige Consumer Healthcare's Receivables had a median value of $171.7 million in 2024 and averaged $175.9 million.
  • Per our database at Business Quant, Prestige Consumer Healthcare's Receivables tumbled by 32.83% in 2021 and then surged by 38.70% in 2022.
  • Prestige Consumer Healthcare's Receivables (Quarterly) stood at $134.3 million in 2021, then grew by 17.00% to $157.1 million in 2022, then rose by 10.95% to $174.3 million in 2023, then decreased by 4.02% to $167.3 million in 2024, then grew by 21.68% to $199.0 million in 2025.
  • Its last three reported values are $199.0 million in Q3 2025, $168.4 million for Q2 2025, and $194.3 million during Q1 2025.